BDI researchers awarded more than $10 million in NHMRC Investigator Grant funding Six Monash Biomedicine Discovery Institute (BDI) researchers have collectively been awarded more than $10 million in National Health and Medical Research Council (NHMRC) Investigator Grants, announced today by Federal Minister for Health and Aged Care The Hon Mark Butler MP. The Investigator Grant scheme is […]
https://rossjohnlab.com/wp-content/uploads/2023/07/Praveena_image-e1741561408562.jpg450600Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2025-03-10 08:43:342025-03-10 09:09:22Congrats Praveena on your NHMRC Investigator Grant funding
In a breakthrough for influenza research, scientists have discovered immune cells that can recognise influenza (flu) viruses even as they mutate, raising hopes for a longer-lasting vaccine and a universal protection against future flu pandemics. The flu virus is constantly evolving, meaning immunity from past infections or vaccinations may not fully protect against new strains. […]
https://rossjohnlab.com/wp-content/uploads/2018/01/14.jpg500500Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2025-02-27 11:53:272025-02-27 11:53:54From Spanish flu to today: how immune cells keep up with a changing virus
Researchers discover how cigarette smoke impairs critical lung immune cells Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory illnesses in incomplete, which has severely hampered the development of effective treatments. In the Journal of Experimental Medicine (JEM) Australian researchers reveal how multiple chemicals found in cigarette smoke and […]
https://rossjohnlab.com/wp-content/uploads/2020/03/Awad_20200303_103548_400px.jpg400400Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2025-01-20 10:54:302025-01-20 10:57:20Where there is smoke .... there is fire - Congrats to co-first author Wael
Monash University-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionised treatment for patients, whereby the body’s own immune system is harnessed to destroy cancer cells. Typically, several molecules restrain the ability of T cells to target cancer cells and developing approaches to limit this restraining effect can lead […]
https://rossjohnlab.com/wp-content/uploads/2018/01/38.jpg500500Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2024-12-16 10:36:042024-12-16 10:36:04Unlocking the potential to better target cancer with immunotherapy
Effective immunity hinges on the ability to sense infection and cellular transformation. In humans, there is a specialised molecule on the surface of cells termed MR1. MR1 allows sensing of certain small molecule metabolites derived from cellular and microbial sources; however, the breadth of metabolite sensing is unclear. Published in PNAS, researchers at the Monash University Biomedicine […]
https://rossjohnlab.com/wp-content/uploads/2020/03/Awad_20200303_103548_400px.jpg400400Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2024-12-03 09:08:332024-12-03 09:08:33Monash study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system
Congrats Praveena on your NHMRC Investigator Grant funding
/in News /by Jennifer HuynhBDI researchers awarded more than $10 million in NHMRC Investigator Grant funding Six Monash Biomedicine Discovery Institute (BDI) researchers have collectively been awarded more than $10 million in National Health and Medical Research Council (NHMRC) Investigator Grants, announced today by Federal Minister for Health and Aged Care The Hon Mark Butler MP. The Investigator Grant scheme is […]
From Spanish flu to today: how immune cells keep up with a changing virus
/in News /by Jennifer HuynhIn a breakthrough for influenza research, scientists have discovered immune cells that can recognise influenza (flu) viruses even as they mutate, raising hopes for a longer-lasting vaccine and a universal protection against future flu pandemics. The flu virus is constantly evolving, meaning immunity from past infections or vaccinations may not fully protect against new strains. […]
Where there is smoke …. there is fire – Congrats to co-first author Wael
/in News /by Jennifer HuynhResearchers discover how cigarette smoke impairs critical lung immune cells Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory illnesses in incomplete, which has severely hampered the development of effective treatments. In the Journal of Experimental Medicine (JEM) Australian researchers reveal how multiple chemicals found in cigarette smoke and […]
Unlocking the potential to better target cancer with immunotherapy
/in News /by Jennifer HuynhMonash University-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionised treatment for patients, whereby the body’s own immune system is harnessed to destroy cancer cells. Typically, several molecules restrain the ability of T cells to target cancer cells and developing approaches to limit this restraining effect can lead […]
Monash study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system
/in News /by Jennifer HuynhEffective immunity hinges on the ability to sense infection and cellular transformation. In humans, there is a specialised molecule on the surface of cells termed MR1. MR1 allows sensing of certain small molecule metabolites derived from cellular and microbial sources; however, the breadth of metabolite sensing is unclear. Published in PNAS, researchers at the Monash University Biomedicine […]